| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| ADMA Biologics (tba) | Oppenheimer/ BMO Capital Markets | $34.50 | n.a. | |||
| Bleach Group (tba) | Wellington Shields & Co. | 3.00 | $5.00 | $6.00 | $16.50 | n.a. |
| Hannon Armstrong Sustainable Infrastructure Capital (tba) | BofA Merrill Lynch/ UBS Investment Bank/ Wells Fargo Securities | $100.00 | n.a. | |||
| Marin Software (MRIN) | Goldman, Sachs/ Deutsche Bank Securities | $75.00 | n.a. | |||
| Model N (MODN) | J.P. Morgan/ Deutsche Bank Securities | $75.00 | n.a. | |||
| Quintiles Transnational Holdings (tba) | Morgan Stanley/ Barclays/ J.P. Morgan | $600.00 | n.a. | |||
| Sophiris Bio (SPHS) | Citigroup/ Leerink Swann | $74.75 | n.a. | |||
| Tetraphase Pharmaceuticals (TTPH) | Barclays/ BMO Capital Markets | $86.25 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| Cancer Genetics (CGIX) | Aegis Capital/ Feltl and Company | 5.00 | $4.00 | $6.00 | $25.00 | 1-Star |
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Cancer Genetics (CGIX) | Aegis Capital/ Feltl and Company | 5.00 | $4.00 | $6.00 | $25.00 | 1-Star |
| Professional Diversity Network (IPDN) | Aegis Capital | 1.82 | $10.00 | $12.00 | $20.02 | 1-Star |
| Taylor Morrison Home (TMHC) | Credit Suisse/ Citigroup/ Zelman Partners | $500.00 | 3-Stars | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Feb. 11, 2013 | Manager(s) | Offered | Raised | Price | 2/15/13 | Change |
| XOOM (XOOM) | Barclays/ Needham | 6.33 | $101.20 | $16.00 | $25.49 | 59.31% |
| ConnectOne Bancorp (CNOB) | Stifel Nicolaus Weisel | 1.60 | $44.80 | $28.00 | $29.65 | 5.89% |
| Orchid Island Capital (ORC) | Ladenburg Thalmann/ Oppenheimer | 2.36 | $35.40 | $15.00 | $14.80 | -1.33% |
